Axogen (AXGN) Trading Update
Axogen Inc. (ticker: AXGN) closed the market up 0.55 % during a 24‑hour period ending at 03:15 PM Central Europe on Friday, 23 October 2026. The share price was USD 36.68 at the close, and the company’s market capitalisation stood at USD 2.1 billion. The total volume traded in the last 24 hours was approximately USD 35.3 million.
Axogen’s price action over the past month shows a decline of 15.33 %. The 200‑day simple moving average is USD 39.23. The stock’s 52‑week high of USD 52.91 was reached on 27 August 2026, while the 52‑week low of USD 17.14 occurred on 28 October 2025.
Trading Activity for Related Stocks (24‑Hour Period)
| Ticker | Company | 24‑Hour Change | Current Price | Market Capitalisation |
|---|---|---|---|---|
| ASAN | Asana, Inc. | +3.07 % | USD 11.50 | USD 2.5 bn |
| KSS | Kohl’s Corp. | +11.82 % | USD 24.78 | USD 2.5 bn |
| CLOV | Clover Health Investments | –0.42 % | USD 4.73 | USD 2.5 bn |
| GCMG | Gcm Grosvenor | –1.19 % | USD 12.62 | USD 2.5 bn |
| BHE | Benchmark Electronics | –6.95 % | USD 66.30 | USD 2.6 bn |
Asana (ASAN)
Asana reported two Rule 144 filings on 22 October 2026. The notices detailed forthcoming sales of common stock by a director‑officer and an officer, covering shares vested from restricted‑stock and performance‑stock units between December 2025 and June 2026. Each filing specified the number of shares to be sold and the anticipated sale date, expected around the end of October. The company did not disclose pricing or proceeds. The filings are routine compliance with SEC reporting requirements.
Kohl’s (KSS)
Kohl’s filed Rule 144 disclosures for the sale of common shares by two senior officers. On 22 October 2026, the company reported that Officer Raymond Christie sold a block of shares earlier in October and again in mid‑October, while Officer Jennifer J. Kent sold a larger block, including a transaction in late October. Both sales were executed through Fidelity Brokerage Services on the NYSE. The filings provide details of the amounts sold, dates, and gross proceeds. An analyst upgrade to a “Buy” rating followed a significant rally in the stock price, citing early signs of a turnaround and a positive price target.
Clover Health Investments (CLOV)
The stock closed down 0.42 % at USD 4.73. No additional corporate events were reported in the 24‑hour period.
Gcm Grosvenor (GCMG)
Gcm Grosvenor’s share price decreased 1.19 % to USD 12.62. The company’s price‑to‑earnings ratio is 22.88, and its market capitalisation is USD 2.5 bn.
Benchmark Electronics (BHE)
Benchmark Electronics fell 6.95 % to USD 66.30. The company’s price‑to‑earnings ratio is 48.65, and its market capitalisation is USD 2.6 bn.
Company Profile – Axogen Inc.
Axogen Inc. is a healthcare equipment and supplies company headquartered in Alachua, Florida, USA. The company specializes in the manufacturing and distribution of medical and surgical instruments for peripheral nerve reconstruction and regeneration. Its product portfolio includes nerve grafts, connectors, and soft tissue membranes. Axogen is listed on the Nasdaq stock exchange. Further information can be found on the company’s website at www.axogeninc.com .
